Showing 61 - 80 results of 1,337 for search '"Fibrosis"', query time: 0.04s Refine Results
  1. 61

    Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis by Argyris Tzouvelekis, Evangelos Bouros, Anastasia Oikonomou, Paschalis Ntolios, George Zacharis, George Kolios, Demosthenes Bouros

    Published 2011-01-01
    “…Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease with ineffective treatment. …”
    Get full text
    Article
  2. 62

    Microscopic Polyangiitis with Pulmonary Fibrosis: An Often-Recognized Manifestation of the Disease by Liam M. Clifford, Jamma Li, Christopher J. Renaud, Suran L. Fernando

    Published 2019-01-01
    “…Pulmonary manifestations including pulmonary fibrosis, emphysema, and bronchiectasis are observed in MPA. …”
    Get full text
    Article
  3. 63

    Hepatic Abscess due to Burkholderia (Pseudomonas) cepacia in Cystic Fibrosis by Kristin L Fraser, Robert H Hyland, D Elizabeth Tullis

    Published 1995-01-01
    “…Two patients with cystic fibrosis are described who developed hepatic abscesses clue to B cepacia. …”
    Get full text
    Article
  4. 64

    Piperacillin-Induced Immune Hemolytic Anemia in an Adult with Cystic Fibrosis by Mahesh Bandara, David B. Seder, George Garratty, Regina M. Leger, Jonathan B. Zuckerman

    Published 2010-01-01
    “…We report a case of drug-induced immune hemolytic anemia (DIIHA) in an adult female with cystic fibrosis (CF), complicating routine treatment of a pulmonary exacerbation with intravenous piperacillin-tazobactam. …”
    Get full text
    Article
  5. 65

    Factors Influencing Oxidative Imbalance in Pulmonary Fibrosis: An Immunohistochemical Study by Simona Inghilleri, Patrizia Morbini, Ilaria Campo, Michele Zorzetto, Tiberio Oggionni, Ernesto Pozzi, Maurizio Luisetti

    Published 2011-01-01
    “…Idiopathic Pulmonary Fibrosis (IPF) is a fatal lung disease of unknown etiology characterized by interstitial fibrosis determining irreversible distortion of pulmonary architecture. …”
    Get full text
    Article
  6. 66

    Exercise Training in Children and Adolescents with Cystic Fibrosis: Theory into Practice by Craig A. Williams, Christian Benden, Daniel Stevens, Thomas Radtke

    Published 2010-01-01
    “…Physical activity and exercise training play an important role in the clinical management of patients with cystic fibrosis (CF). Exercise training is more common and recognized as an essential part of rehabilitation programmes and overall CF care. …”
    Get full text
    Article
  7. 67
  8. 68
  9. 69
  10. 70

    Treatment of Pseudomonas and Staphylococcus Bronchopulmonary Infection in Patients with Cystic Fibrosis by Rashmi Ranjan Das, Sushil Kumar Kabra, Meenu Singh

    Published 2013-01-01
    “…The optimal antibiotic regimen is unclear in management of pulmonary infections due to pseudomonas and staphylococcus in cystic fibrosis (CF). We systematically searched all the published literature that has considered the evidence for antimicrobial therapies in CF till June 2013. …”
    Get full text
    Article
  11. 71

    Celiac Disease in Patients with Cystic Fibrosis-Related Bone Disease by Melissa S. Putman, Alexandra Haagensen, Isabel Neuringer, Leonard Sicilian

    Published 2017-01-01
    “…Both cystic fibrosis (CF) and celiac disease can cause low bone mineral density (BMD) and fractures. …”
    Get full text
    Article
  12. 72
  13. 73

    Pengaruh Valsartan Terhadap Fibrosis Ginjal pada Obstruksi Ureter by Alvarino .

    Published 2012-09-01
    “…ResultFrom thirteen wistar rats in no treatment group, two of them<br />having moderate interstitial fibrosis and eleven with mild interstitial fibrosis while all rats in valsartan group had mild<br />interstitial fibrosis (p &gt; 0.05). …”
    Get full text
    Article
  14. 74
  15. 75

    Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets by Hai Li, Hong You, Jidong Jia, Xu Fan

    Published 2016-05-01
    “…Many studies demonstrated that while hepatic macrophages promoted fibrosis through the recruitment of proinflammatory immune cells, and the secretion of proinflammatory cytokines and chemokines in the early stages, these also promoted the resolution of hepatic fibrosis through the secretion of matrix metalloproteinases in the late stages. …”
    Get full text
    Article
  16. 76

    Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection by Michele Barone, Maria Teresa Viggiani, Annabianca Amoruso, Serafina Schiraldi, Annapaola Zito, Fiorella Devito, Francesca Cortese, Michele Gesualdo, Natale Brunetti, Alfredo Di Leo, Pietro Scicchitano, Marco Matteo Ciccone

    Published 2015-01-01
    “…To clarify the role of HCV in atherosclerosis development in monoinfected HCV patients at different degrees of liver fibrosis and with no risk factors for coronary artery disease. …”
    Get full text
    Article
  17. 77
  18. 78

    Potential Role of the Inflammasome-Derived Inflammatory Cytokines in Pulmonary Fibrosis by Rupa Biswas, Melisa Bunderson-Schelvan, Andrij Holian

    Published 2011-01-01
    “…Pulmonary fibrosis is a progressive, disabling disease with mortality rates that appear to be increasing in the western population, including the USA. …”
    Get full text
    Article
  19. 79

    Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease by Elena Buzzetti, Rosa Lombardi, Laura De Luca, Emmanuel A. Tsochatzis

    Published 2015-01-01
    “…Noninvasive fibrosis tests have been extensively developed recently and offer alternatives for staging fibrosis. …”
    Get full text
    Article
  20. 80

    Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography by Hugo Perazzo, Valdilea G. Veloso, Beatriz Grinsztejn, Chris Hyde, Rodolfo Castro

    Published 2015-01-01
    “…Transient elastography (TE) based on liver stiffness measurement (LSM) is one of the most validated noninvasive methods for liver fibrosis staging in patients with chronic liver diseases. …”
    Get full text
    Article